Mylife Pura blood glucose strips 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Bionime Corporation 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2012-02-22
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Press release
  • 원인
    Recall of mylife pura blood glucose strips in france the department of health (dh) today (february 22) drew the public's attention to the recall of certain lots of a blood glucose test strip in france. the affected product is mylife pura (box of 100) manufactured by bionime corporation. the test strips may give falsely high blood glucose readings. the dh was informed by the french medical device regulatory authority, agence francaise de sécurité sanitaire des produits de santé (afssaps), about the recall. according to afssaps, the problem came to their notice when several reports of overestimation of blood glucose levels were received. further investigation revealed that the problem was due to the accidental opening of the unsealed vials of the test strips during transportation from the distributor in france to the pharmacies. as the test strips are very sensitive to air exposure, they may lose performance and give falsely high readings. the manufacturer has since then taken preventive action by starting to seal all the vials with a protective film. a spokesman for the dh explained that falsely high blood glucose readings may mislead a diabetic patient into inappropriate management of his or her condition, resulting in hypoglycaemia - indeed, such a case has been reported in france. so far, the dh has not received any local report of adverse events arising from use of the product. although there is currently no readily available evidence to suggest that the affected product has ever been exported to hong kong, the dh is following up with the manufacturer to verify that this is indeed the case. meanwhile, as a precautionary measure, members of the public who may have the above product in their hands are advised to stop using any vials which came unsealed and surrender them to the dh's medical device control office at room 3101, 31/f, hopewell centre, 183 queen's road east, wan chai. "for those customers who have used the said product and are either feeling unwell or in doubt, they should consult their health-care professionals for advice as soon as possible," the spokesman said. ends.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Press release: Recall of Mylife Pura blood glucose strips in France
  • Manufacturer

Manufacturer